Immunomedics (IMMU) Acquisition
Gilead Sciences (GILD) and Immunomedics (IMMU) $21bn acquisition information including expected completion date, offer price and contact details are displayed in the acquisition details table below. An invaluable buyout factsheet…
Continue Reading Immunomedics (IMMU) Acquisition